And when she did, she was diagnosed with psoriatic arthritis ... may temporarily stop treatment with COSENTYX if you develop ...

Psoriatic arthritis surgery could involve removing damaged tissue or bone or replacing a joint with severe damage. Learn more ...

Plaque psoriasis (PsO) and psoriatic arthritis (PsA) are lifelong conditions that can have a significant impact on those ...

Juvenile idiopathic arthritis symptoms may only affect certain joints. Some children have systemic reactions, such as rash.

Rashes are a common symptom ... of this condition must receive appropriate treatment. What is a person’s life expectancy with psoriatic arthritis? PsA does not usually affect life expectancy ...

should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous manifestations of psoriatic disease need to be considered in treatment targets.

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

Tremfya (guselkumab) is a prescription drug that’s used to treat certain inflammatory conditions, such as psoriatic arthritis ... only for UC at the start of treatment.) Tremfya contains ...

The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...

When compared with other biologic therapies, patients with psoriasis receiving IL-23 inhibitors had a lower risk for inflammatory arthritis or psoriatic arthritis development.

A 40-year-old man presented to the emergency department with a 5-day history of fevers, sore throat, fatigue, subjective ...

The global psoriatic arthritis (PsA) treatment market is poised for remarkable expansion, with an anticipated valuation of ...